

COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.
You can purchase shares of Cocrystal Pharma (NASDAQ:COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Cocrystal Pharma has a consensus price target of $6.00.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $0.9301 last updated October 23, 2026 at 8:28 AM EDT.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and...